Geir Larsson

  • Consultant; MD, PhD
  • +47 920 45 245

Education

  • Md University of Pecs, Hungary (2003)
  • PhD University of Oslo (2015)
  • Norwegian clinical specialist accreditations. Internal medicine and gastroenterology (2018)

Current position

Consultant, Department of gastroenterology, Oslo University Hospital

 

Publications 2020

Hedin CRH, Sado G, Ndegwa N, Lytvyak E, Mason A, Montano-Loza A, Gerussi A, Saffioti F, Thorburn D, Nilsson E, Larsson G, Moum BA, van Munster KN, Ponsioen CY, Levy C, Nogueira NF, Bowlus CL, Gotlieb N, Shibolet O, Lynch KD, Chapman RW, Rupp C, Vesterhus M, Jørgensen KK, Rorsman F et al. (2020)
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
Clin Gastroenterol Hepatol, 18 (10), 2295-2304.e2
DOI 10.1016/j.cgh.2020.02.014, PubMed 32068151

Publications 2016

Larsson G (2016)
[Not Available]
Tidsskr Nor Laegeforen, 136 (14-15), 1266
DOI 10.4045/tidsskr.16.0477, PubMed 27554580

Publications 2014

Larsson G, Shenoy KT, Ramasubramanian R, Thayumanavan L, Balakumaran LK, Bjune GA, Moum BA (2014)
Faecal calprotectin levels differentiate intestinal from pulmonary tuberculosis: An observational study from Southern India
United European Gastroenterol J, 2 (5), 397-405
DOI 10.1177/2050640614546947, PubMed 25360318

Larsson G, Shenoy KT, Ramasubramanian R, Thayumanavan L, Balakumaran LK, Bjune GA, Moum BA (2014)
High faecal calprotectin levels in intestinal tuberculosis are associated with granulomas in intestinal biopsies
Infect Dis (Lond), 47 (3), 137-43
DOI 10.3109/00365548.2014.974206, PubMed 25522183

Larsson G, Shenoy T, Ramasubramanian R, Balakumaran LK, Småstuen MC, Bjune GA, Moum BA (2014)
Routine diagnosis of intestinal tuberculosis and Crohn's disease in Southern India
World J Gastroenterol, 20 (17), 5017-24
DOI 10.3748/wjg.v20.i17.5017, PubMed 24803814